Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Lionmesh Prima Tbk. (LMSH) Price & Performance

UBC Medical Indonesia Tbk.Trade
Lionmesh Prima Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Lionmesh Prima Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Lionmesh Prima Tbk. trades at Rp256 (market cap 24.58B). The key difference: UBC Medical Indonesia Tbk. is far larger — about 28.1× Lionmesh Prima Tbk.'s market cap. Which is the better fit depends on your goals.

LABSLMSH
Market Cap
691.25B24.58B
Volume
635.5K
Lot
6.36K
Turnover
110.15M
Average Price
173.33
Value
110.15M
Indicative Equilibrium Price
174
Indicative Equilibrium Volume
50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
LMSH
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Lionmesh Prima Tbk.

PT Lionmesh Prima Tbk (the Company) was originally under the name PT Lion Weldmesh Prima and established on December 14, 1982. The Company its started commercial operations in 1984.

Read more on LMSH